Researchers at the John Innes Centre at Norwich Research Park have helped to solve a historical puzzle that could revolutionise the breeding of the humble pea and other legumes leading to improvements in their nutritional value and lessening the reliance on pesticides.
Global drug development consultancy Boyds has appointed a Vice President of Regulatory Affairs in response to growing demand for its specialist services and expertise.
We're seeking a quantitative researcher passionate about uncovering novel correlations within complex life science and healthcare datasets. This role offers the opportunity to develop advanced computational tools and algorithms, enhancing our analytical platforms and pushing the boundaries of what's possible in data science.
Dr Cary Fowler, former US Special Envoy for Global Food Security and 2024 World Food Prize winner will be delivering this year’s John Innes Foundation Lecture, ‘Trends – Trouble – Tenacity: The food security picture for 2050’. It will be held at the John Innes Conference Centre at Norwich Research Park starting from 1.30-2.30pm on Friday 23 May.
Join Pioneer Group and the UK Alliance for Sustainable Chemicals and Materials (UK-ASCM), for this exciting event focused on driving innovation, collaboration, and a greener future for the chemical industry.
Join industry leaders, innovators, policymakers, and researchers at the UK Sustainable Chemicals Summit 2025, the premier event dedicated to advancing sustainability in the chemicals sector.
With the UK government targeting 1.5 million new homes by 2030 and retrofitting 19 million by 2050, the pressure is on to meet housing demands, while significantly reducing emissions. The built environment currently accounts for 33% of the UK’s carbon footprint—so how do we build better, and greener?
Join Pioneer Group and Innovate UK Business Connect, for this exciting event focused on defossilising the UK chemicals industry, which will see the launch of the new Innovate UK Business Connect ‘Sustainable Chemicals Innovation Network’.
Registration is free, spaces are limited – secure your place today!
Why attend?
Bringing together leaders from industry, government, academia and the investment community to explore how we can accelerate the transition toward a more sustainable, circular and globally competitive chemicals sector.
Isomerase has announced the launch of EvoSelect®, a machine learning-guided enzyme engineering platform designed to accelerate development timelines, enhance performance under industrial conditions, and reduce the cost and complexity of enzyme optimisation. EvoSelect® forms part of Isomerase’s broader IsoZym™ platform, an end-to-end offering that spans protein design, expression, and scale-up.
Cambridge, UK, 8th May 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces the sale of rights to certain non-Ogluo® products from the portfolio of its Tetris Pharma subsidiary to Aspire Pharma Limited (“Aspire”).